Third degree AV block primary prevention: Difference between revisions
Jump to navigation
Jump to search
| Line 2: | Line 2: | ||
===Overview=== | ===Overview=== | ||
==Primary prevention== | ==Primary prevention== | ||
*Effective measurement for primary prevention of [[atrioventricular block]] due to [[dogoxin toxicity]] in [[patients]] with [[renal insufficiency]] is avoidance of [[dehydration]], [[electrolytes imbalance]]. | *Effective measurement for primary prevention of [[atrioventricular block]] due to [[dogoxin toxicity]] in [[patients]] with [[renal insufficiency]] is avoidance of [[dehydration]], and [[electrolytes imbalance]]. | ||
* [[Patients]] with renal insufficiency, [[potassium]], [[electrolyte disturbances]], and [[dehydration]] are predisposed to develop [[digoxin toxicity]]. | * [[Patients]] with renal insufficiency, [[potassium]], [[electrolyte disturbances]], and [[dehydration]] are predisposed to develop [[digoxin toxicity]]. | ||
* Careful monitoring of electrolytes, drug levels, and [[renal function]] is essential in [[patients]] on [[chronic]] [[digoxin ]] therapy. | * Careful monitoring of electrolytes, drug levels, and [[renal function]] is essential in [[patients]] on [[chronic]] [[digoxin ]] therapy. | ||
* [[Patients] on multiple AV nodal blocker agents (e.g., [[beta-blockers]] and [[calcium channel blockers]]) are at an increased risk for the development of [[atrioventricular (AV) block ]]. | * [[Patients]] on multiple [[AV nodal blocker]] agents (e.g., [[beta-blockers]] and [[calcium channel blockers]]) are at an increased risk for the development of [[atrioventricular (AV) block ]]. | ||
* These [[patients]] should be carefully monitored for [[heart blocks]]. | * These [[patients]] should be carefully monitored for [[heart blocks]]. | ||
Revision as of 07:22, 1 July 2021
Overview
Primary prevention
- Effective measurement for primary prevention of atrioventricular block due to dogoxin toxicity in patients with renal insufficiency is avoidance of dehydration, and electrolytes imbalance.
- Patients with renal insufficiency, potassium, electrolyte disturbances, and dehydration are predisposed to develop digoxin toxicity.
- Careful monitoring of electrolytes, drug levels, and renal function is essential in patients on chronic digoxin therapy.
- Patients on multiple AV nodal blocker agents (e.g., beta-blockers and calcium channel blockers) are at an increased risk for the development of atrioventricular (AV) block .
- These patients should be carefully monitored for heart blocks.